Myomo - 2 Year Stock Price History | MYO
Historical daily share price chart and data for Myomo since 2017 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Myomo as of January 22, 2019 is 1.66.
| Myomo Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 1.6015 | 1.5500 | 1.7500 | 1.5016 | 1.6600 | 15.28% |
| 2018 | 2.8421 | 3.6500 | 5.4000 | 1.4400 | 1.4400 | -61.60% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.021B | $0.002B |
| Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $125.560B | 25.44 |
| Medtronic (MDT) | Ireland | $116.845B | 17.47 |
| Stryker (SYK) | United States | $62.070B | 23.40 |
| Boston Scientific (BSX) | United States | $51.560B | 26.06 |
| Baxter (BAX) | United States | $37.069B | 23.94 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.197B | 13.75 |
| ResMed (RMD) | United States | $16.739B | 31.92 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.480B | 0.00 |
| Canopy Growth (CGC) | Canada | $10.136B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.056B | 45.12 |
| Hill-Rom Holdings (HRC) | United States | $6.447B | 20.36 |
| Aurora Cannabis (ACB) | Canada | $6.178B | 32.58 |
| Perrigo (PRGO) | Ireland | $6.105B | 9.27 |
| Haemonetics (HAE) | United States | $5.072B | 44.61 |
| ICU Medical (ICUI) | United States | $4.894B | 27.27 |
| Insulet (PODD) | United States | $4.517B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.200B | 0.00 |
| Neogen (NEOG) | United States | $3.138B | 48.21 |
| Agios Pharmaceuticals (AGIO) | United States | $3.041B | 0.00 |
| Hutchison China MediTech (HCM) | China | $2.918B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.467B | 47.72 |
| NuVasive (NUVA) | United States | $2.457B | 22.87 |
| Quidel (QDEL) | United States | $2.042B | 26.63 |
| NxStage Medical (NXTM) | United States | $1.891B | 0.00 |
| Aphria (APHA) | $1.768B | 78.67 | |
| Phibro Animal Health (PAHC) | United States | $1.259B | 17.82 |
| AtriCure (ATRC) | United States | $1.203B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.038B | 20.79 |
| Cardiovascular Systems (CSII) | United States | $1.001B | 1441.00 |
| PetIQ (PETQ) | United States | $0.788B | 20.43 |
| Cerus (CERS) | United States | $0.764B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.739B | 41.59 |
| Meridian Bioscience (VIVO) | United States | $0.703B | 22.42 |
| Omeros (OMER) | United States | $0.651B | 0.00 |
| Surmodics (SRDX) | United States | $0.645B | 97.61 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.627B | 20.11 |
| Lantheus Holdings (LNTH) | United States | $0.625B | 19.36 |
| NanoString Technologies (NSTG) | United States | $0.623B | 0.00 |
| MacroGenics (MGNX) | United States | $0.487B | 0.00 |
| Owens & Minor (OMI) | United States | $0.481B | 5.44 |
| Quanterix (QTRX) | United States | $0.449B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.449B | 22.04 |
| Evolus (EOLS) | United States | $0.443B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.361B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.314B | 20.31 |
| Insys Therapeutics (INSY) | United States | $0.305B | 0.00 |
| Bovie Medical (APYX) | United States | $0.280B | 0.00 |
| Vapotherm (VAPO) | United States | $0.273B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.268B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.230B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.229B | 310.00 |
| Rockwell Medical (RMTI) | United States | $0.178B | 0.00 |
| Fonar (FONR) | United States | $0.137B | 6.88 |
| Chimerix (CMRX) | United States | $0.132B | 0.00 |
| Surface Oncology (SURF) | United States | $0.132B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.120B | 0.00 |
| United-Guardian (UG) | United States | $0.086B | 18.00 |
| Female Health (VERU) | United States | $0.085B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.069B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.060B | 16.73 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.059B | 0.00 |
| CAS Medical Systems (CASM) | United States | $0.056B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Neurotrope (NTRP) | United States | $0.031B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.020B | 0.00 |
| Senestech (SNES) | United States | $0.019B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.017B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.014B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
